Re: FW: OAXAL Webinar

Hi Andrea,

I do need the webinar description to set a date and begin outreach -- Let's start with a date and a very compelling message; here is a good example from a past webinar:

OASIS invites you to attend a free, 30-minute webinar outlining the upcoming activities of the new DITA Pharmaceutical Content Subcommittee. The group is bringing together pharmaceutical documentation experts from all regions to define DITA topics and maps, as well as associated metadata and terminology. The output of this Committee will address good practices as well as proposed DITA specialization; all stakeholders are strongly encouraged to be represented.

The webinar will provide examples of how the group’s recommendations may be used to streamline the creation of documentation supporting a product for scientific and regulatory purposes throughout its lifecycle.

While the actual scope and schedule will be determined by the Committee, some of the early topics may include:

- ICH Common Technical Document;

- FDA Structured Product Labeling;

- EU Product Information Management; and

- Clinical Trial Protocol and Study Reports.

Who should attend:

Anyone with an interest in participating in or monitoring the work of the DITA Pharmaceutical Content Subcommittee including:

* Medical and technical writers for pharmaceutical companies

* Information technology architects with specialization in content and document management

* Researchers who have expertise in the design of drug development programs,

Reference links:

* DITA Pharmaceutical Content SC Statement of Work

http://lists.oasis-open.org/archives/dita/200905/pdf00000.pdf

* OASIS DITA Technical Committee

http://www.oasis-open.org/committees/dita/

* OASIS Membership

http://www.oasis-open.org/join/categories.php

I don't need the entire slideset yet. Can we set the presenters date and the description now?

Best,

Dee

Dee Schur, Senior Manager - Standards Advocate

OASIS: Advancing open standards for the information society

http://www.oasis-open.org

+1.978.667.5115 x211

-----Original Message-----
From: Andrzej Zydron [mailto:azydron@xtm-intl.com]
Sent: Friday, September 17, 2010 7:20 AM
To: Dee Schur
Cc: oaxal@lists.oasis-open.org
Subject: Re: FW: OAXAL Webinar

Hi Dee,

It has taken quite a while, but last Friday the OAXAL TC agreed the

content of the webinar. The presentation is too big (4.7Mb) to be

accepted by the OASIS mail gateway. Is there any other way I can send it

to you?

45 minutes would be ideal for the webinar. The presentation itself takes

about 35 minutes leaving 10 minutes for Q&As. Best Regards,

> AZ

> On 30/04/2010 22:46, Dee Schur wrote:

>> Please send along a description as soon as you have it prepared. Will 30

>> minutes be enough for you and Bryan?

>> Thanks,

>> Dee

>> Dee Schur, Member Support

>> OASIS: Advancing open standards for the information society

>> http://www.oasis-open.org

>> +1.978.667.5115 x211

>> -----Original Message-----

>> From: Andrzej Zydron [mailto:azydron@xml-intl.com]

>> Sent: Thursday, April 22, 2010 9:38 AM

>> To: Dee Schur

>> Cc: 'Jane Harnad'; 'Carol Geyer'

>> Subject: Re: FW: OAXAL Webinar

>> Hi Dee,

>> I would present with perhaps Bryan Schnabel. I would go for mid June. 30

>> Minutes would be fine. I can get the message across in that time. I

>> already have quite a few materials available to work with.

>> Best Regards,

>> AZ

>> On 21/04/2010 21:49, Dee Schur wrote:

>>> Hi Andrzej,

>>> I'd be happy to discuss a webinar with you. What time frame are you

>> shooting

>>> for? How many presenters? Here is an example of a very successful

>>> webinar

>>> description:

>>> ***********************************************************************

>>> OASIS invites you to attend a free, 30-minute webinar outlining the

>> upcoming

>>> activities of the new DITA Pharmaceutical Content Subcommittee. The

>>> group

>> is

>>> bringing together pharmaceutical documentation experts from all

>>> regions to

>>> define DITA topics and maps, as well as associated metadata and

>> terminology.

>>> The output of this Committee will address good practices as well as

>> proposed

>>> DITA specialization; all stakeholders are strongly encouraged to be

>>> represented.

>>>

>>> The webinar will provide examples of how the group's recommendations

>>> may

>> be

>>> used to streamline the creation of documentation supporting a

>>> product for

>>> scientific and regulatory purposes throughout its lifecycle.

>>>

>>> While the actual scope and schedule will be determined by the

>>> Committee,

>>> some of the early topics may include:

>>> - ICH Common Technical Document;

>>> - FDA Structured Product Labeling;

>>> - EU Product Information Management; and

>>> - Clinical Trial Protocol and Study Reports.

>>>

>>> Who should attend:

>>> Anyone with an interest in participating in or monitoring the work

>>> of the

>>> DITA Pharmaceutical Content Subcommittee including:

>>>

>>> * Medical and technical writers for pharmaceutical companies

>>> * Information technology architects with specialization in content and

>>> document management

>>> * Researchers who have expertise in the design of drug development

>> programs,

>>>

>>> Reference links:

>>>

>>> * DITA Pharmaceutical Content SC Statement of Work

>>> http://lists.oasis-open.org/archives/dita/200905/pdf00000.pdf

>>>

>>> * OASIS DITA Technical Committee

>>> http://www.oasis-open.org/committees/dita/

>>>

>>> * OASIS Membership

>>> http://www.oasis-open.org/join/categories.php

>>>

>>> Title: Defining DITA for Pharmaceutical Documentation

>>> *******************************************************************

>>>

>>> I would need a similar description for OAXAL. Looking forward to

>>> hearing

>>> from you.

>>> Best,

>>> Dee

>>>

>>> Dee Schur, Member Support

>>> OASIS: Advancing open standards for the information society

>>> http://www.oasis-open.org

>>> +1.978.667.5115 x211

>>>

>>> -----Original Message-----

>>> From: Mary McRae [mailto:mary.mcrae@oasis-open.org]

>>> Sent: Saturday, April 17, 2010 10:32 AM

>>> To: Andrzej Zydron; Carol Geyer

>>> Subject: Re: OAXAL Webinar

>>>

>>> Hi Andrzej,

>>>

>>> That's great! I'm copying Carol on this message; she'll be happy to put

>> you

>>> in touch with either Jane or Dee to work out the details!

>>>

>>> Mary

>>>

>>> On Apr 17, 2010, at 8:57 AM, Andrzej Zydron wrote:

>>>

>>>> Hi Mary,

>>>>

>>>> As part if the OAXAL proselytizing activity I would like to organize a

>>>>

>>> webinar about OAXAL for all OASIS members and anyone outside of

>>> OASIS who

>>> would be interested.

>>>

>>>> How do I go about organizing this?

>>>>

>>>> Thank you in advance,

>>>>

>>>> AZ

>>>>

>>>> --

>>>> email - azydron@xml-intl.com

>>>> smail - c/o Mr. A.Zydron

>>>> PO Box 2167

>>>> Gerrards Cross

>>>> Bucks SL9 8XF

>>>> United Kingdom

>>>> Mobile +(44) 7966 477 181

>>>> FAX +(44) 1753 480 465

>>>> www - http://www.xml-intl.com

>>>>

>>>> This message contains confidential information and is intended only

>>>> for the individual named. If you are not the named addressee you may

>>>> not disseminate, distribute or copy this e-mail. Please notify the

>>>> sender immediately by e-mail if you have received this e-mail by

>>>> mistake and delete this e-mail from your system.

>>>> E-mail transmission cannot be guaranteed to be secure or error-free as

>>>> information could be intercepted, corrupted, lost, destroyed, arrive

>>>> late or incomplete, or contain viruses. The sender therefore does not

>>>> accept liability for any errors or omissions in the contents of this

>>>> message which arise as a result of e-mail transmission. If

>>>> verification is required please request a hard-copy version. Unless

>>>> explicitly stated otherwise this message is provided for informational

>>>> purposes only and should not be construed as a solicitation or offer.

>>>>

>>>> <azydron.vcf>

>>>>

>>>

email - azydron@xtm-intl.com

smail - c/o Mr. A.Zydron

PO Box 2167

Gerrards Cross

Bucks SL9 8XF

United Kingdom

Mobile +(44) 7966 477 181

FAX +(44) 1753 480 465

www - http://www.xtm-intl.com

This message contains confidential information and is intended only for

the individual named. If you are not the named addressee you may not

disseminate, distribute or copy this e-mail. Please notify the sender

immediately by e-mail if you have received this e-mail by mistake and

delete this e-mail from your system.

E-mail transmission cannot be guaranteed to be secure or error-free as

information could be intercepted, corrupted, lost, destroyed, arrive

late or incomplete, or contain viruses. The sender therefore does not

accept liability for any errors or omissions in the contents of this

message which arise as a result of e-mail transmission. If verification

is required please request a hard-copy version. Unless explicitly stated

otherwise this message is provided for informational purposes only and

should not be construed as a solicitation or offer.

oaxal message